Shkreli: Mallinckrodt Is A Terrible Short
March 22, 2017 at 11:06 AM EDT
A day after Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) announced plans to develop a lower-priced alternative to Mallinckrodt PLC (NYSE: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.